Davis Capital Management’s Pfizer PFE Stock Holding History

Davis Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.3K	Buy	137 +87	+174%	+$2.28K	﹤0.01%	347
2026 Q1	$1.4K	Hold	50	–	–	﹤0.01%	313
2025 Q4	$1.25K	Sell	50 -11	-18%	-$277	﹤0.01%	318
2025 Q3	$1.55K	Buy	+61	New	+$1.51K	﹤0.01%	313
2024 Q1	–	Sell	-140	Closed	-$4.03K	–	298
2023 Q4	$4.03K	Buy	+140	New	+$4.23K	﹤0.01%	255
2020 Q2	$668K	Buy	21,527 +2,608	+14%	+$88.6K	1.23%	33
2020 Q1	$586K	Buy	+18,919	New	+$645K	1.24%	29

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Davis Capital Management's PFE Position: Q2 2026 in Review

Davis Capital Management increased its Pfizer (PFE) stake by 174% in Q2 2026, buying an estimated $2.28K and bringing the position to 137 shares worth $3.3K. The position accounts for ﹤0.01% of the portfolio, ranked #347.

Davis Capital Management first reported a position in PFE in Q1 2020 and has held it in 7 quarters since. The position peaked at $668K in Q2 2020. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Davis Capital Management held 137 shares of Pfizer worth $3.3K as of Q2 2026.
Davis Capital Management bought 87 Pfizer shares in Q2 2026, an estimated $2.28K.
Pfizer made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #347 holding.
Davis Capital Management first reported a position in Pfizer in Q1 2020 and has held it in 7 quarters since.
Davis Capital Management's Pfizer position peaked at $668K in Q2 2020.
900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.